$4.7983
-0.0117[-0.24%]
At close: Apr 26
$4.7983
0[0.00%]
After Hours: 5:46PM EDT
Lipocine
(NASDAQ:LPCN)Lipocine Stock (NASDAQ:LPCN), Analyst Ratings, Price Targets, Predictions
Lipocine Inc has a consensus price target of $18.25, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, HC Wainwright & Co., and Cantor Fitzgerald on July 27, 2023, August 26, 2021, and June 24, 2021. With an average price target of $13.17 between Cantor Fitzgerald, HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 174.40% upside for Lipocine Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Lipocine
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/27/2023 | LPCN | Buy Now | Lipocine | $4.80 | 587.74% | Cantor Fitzgerald | Jennifer Kim | → $33 | Reiterates | Overweight → Overweight | Get Alert |
| 08/26/2021 | LPCN | Buy Now | Lipocine | $4.80 | -27.06% | HC Wainwright & Co. | Oren Livnat | — | Maintains | Buy | Get Alert |
| 06/24/2021 | LPCN | Buy Now | Lipocine | $4.80 | -37.48% | Cantor Fitzgerald | Jennifer Kim | — | Initiates | → Overweight | Get Alert |
| 05/27/2021 | LPCN | Buy Now | Lipocine | $4.80 | -47.9% | HC Wainwright & Co. | Oren Livnat | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Lipocine (LPCN)?
The latest price target for Lipocine (NASDAQ: LPCN) was reported by Cantor Fitzgerald on July 27, 2023. The analyst firm set a price target for $33.00 expecting LPCN to rise to within 12 months (a possible 587.74% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lipocine (LPCN)?
The latest analyst rating for Lipocine (NASDAQ: LPCN) was provided by Cantor Fitzgerald, and Lipocine reiterated their overweight rating.
When was the last upgrade for Lipocine (LPCN)?
There is no last upgrade for Lipocine.
When was the last downgrade for Lipocine (LPCN)?
There is no last downgrade for Lipocine.
When is the next analyst rating going to be posted or updated for Lipocine (LPCN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lipocine, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lipocine was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
Is the Analyst Rating Lipocine (LPCN) correct?
While ratings are subjective and will change, the latest Lipocine (LPCN) rating was a reiterated with a price target of $0.00 to $33.00. The current price Lipocine (LPCN) is trading at is $4.80, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.